BryoSphere Biotechnologies
Transforming moss into living factories to make bioactive skincare ingredients
About Bryosphere
From Moss to Modern Skincare
At BryoSphere, we are harnessing 500 million years of moss evolution to create bioactive ingredients for skincare. Our ingredients address a range of skin concerns such as hyperpigmentation, inflammation and UV damage.
Sustainable Production with Moss
Our proprietary moss biomanufacturing platform enables production of high-quality bioactive ingredients at large scales. We offer a reliable and sustainable solution for beauty brands committed to eco-friendly sourcing.
Plant Science, Redefined
At BryoSphere, our mission is to create a scalable platform that delivers high-quality ingredients for skincare and beyond. With our cost efficient, scalable solution, we are unlocking the incredible biochemistry of the plant kingdom!
About
Liz Mahon, Ph.D.
Co-founder & CEO
Dr. Mahon is a plant geneticist and biotechnology leader with deep expertise in plant genetics and biochemistry, holding both an M.Sc. and Ph.D. Her work centers on applying advanced biotechnology tools to address climate change challenges. During her doctoral research at the University of British Columbia, she engineered novel biochemical pathways into target plant systems to enhance feedstock value for biofuel applications. She brings extensive experience across molecular biology and biochemistry techniques, translating innovative plant science into scalable, real-world solutions.
Hila Behar, Ph.D.
Co-founder & CTO
Dr. Hila Behar is a scientist and entrepreneur with extensive experience leading and executing innovative research initiatives. She earned her Ph.D. from the University of British Columbia, where she conducted multidisciplinary research in plant biochemistry and protein characterization. During this time, she founded a moss research center and engineered modified moss strains for the production of enzymes with applications in biofuels and sustainable biotechnology. Shortly after graduating, she co-founded BryoSphere Biotechnologies with Liz, translating her research expertise into scalable moss-based technologies for high-value commercial applications.
Maisha Farzana Ph.D.
Senior Scientist
Dr. Maisha Farzana earned her PhD from the University of New Brunswick, where she focused on reconstituting complex plant secondary metabolic pathways within microbial and novel plant hosts. With deep expertise in chemical characterization and isolation of plant secondary metabolites, she bridges the fields of plant biology and biotechnology to unlock the potential of natural compounds. Her passion for scientific discovery and meticulous approach to research make her an invaluable member of our team.
Sheree Wiener, MBA
Advisor
Sheree Wiener is a seasoned professional with over 25 years of leadership experience in the skincare and beauty industry. She has held pivotal roles, including Vice President of Product Development at Kate Somerville Skincare, Senior Director of Global Product Development at Arbonne, and Head of Marketing at Allergan. In addition to her executive leadership roles, Sheree has spent many years consulting for industry leaders such as Genentech, GlaxoSmithKline, Obagi, Allergan and SkinMedica, Novartis, Ever Skincare, and Modere. Her deep expertise in product development, coupled with her extensive industry connections, highlights her ability to bridge innovation and market needs. Her knowledge of regulatory pathways, marketing strategies, and customer acquisition positions her as a valuable asset in fostering BryoSphere's growth and establishing strong partnerships with leading skincare brands.
Karen Boodram, MBA
Advisor
Karen Boodram boasts a distinguished 30-year+ career focused on enhancing patient health through the commercialization of cutting-edge medical technologies. Her extensive expertise spans the pharmaceutical realm, where she led the development of drug products/franchises, orchestrating their regulatory compliance, clinical development and marketing. Transitioning into the financial sector, Karen's role as a Life Science analyst centered on propelling the medical innovations of public Life Science companies into commercialization or acquisition. Karen's academic achievements include an MBA, BSc.Pharm., and BSc. Bioch., underlining her knowledge and experience in merging medical innovation with business acumen for improved drug development.
Anthony Marotta, Ph.D.
Advisor
Dr. Anthony Marotta, Ph.D., is a serial entrepreneur focused on innovative health and wellness solutions. A proven scientific and clinical leader, Marotta co-founded Augurex Life Sciences Corp and Peqish Food Group. In his eleven-year tenure at Augurex, he led the development of 14-3-3η biomarker programs, securing approvals and launches globally. At Peqish, Marotta played a crucial role in differentiating the business with a "food is medicine" approach, achieving double-digit profitability. Previously, he served as Director of Business Development at Stressgen Bioreagents, strategically expanding the product portfolio. Marotta holds several patents, has co-authored and presented at various international conferences, and has strong relationships with clinicians worldwide. Marotta began his career in research at Kinetek Pharmaceuticals whilst pursuing his Ph.D. in Experimental Medicine at the University of British Columbia.
Interested in partnering with us or learning more?
We would love to hear from you!
Proudly supported by:
